Geno.Me, Inc.
Milwaukee, US · Founded 2020 · Wisconsin corporation · 2 known investors
Founders & leadership
PA
Paul AuerNamed on SEC filing
BG
Brittany GottschalkNamed on SEC filing
Board
LH

MB

Investors · 2
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2022–2025
▶$200KraisedMay 2025 · 2 investors · Other TechnologyRule 506(b)
▶$200KraisedMay 2025 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul AuerDirector
- Brittany GottschalkExecutive Officer, Director
- Laura HiltyDirector
- Offering amount
- $650K
- Amount sold
- $200K
- First sale
- Apr 2025
- Incorporated
- Corporation, Wisconsin, 2020
- Federal exemptions
- 06b
▶$2.2MraisedOct 2022 · 3 investors · Other TechnologyRule 506(b)
▶$2.2MraisedOct 2022 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul AuerDirector
- Brittany GottschalkExecutive Officer, Director
- Mark BakkenDirector
- Offering amount
- $3.3M
- Amount sold
- $2.2M
- First sale
- Sep 2022
- Incorporated
- Corporation, Wisconsin, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Legal entities · 1
corporate structureGeno.Me, Inc.Wisconsin
▸Research sources · 3
primary sources listed
- mergers & acquisitions Genetics & Genomics News | GenomeWebgenomeweb.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- Who are Geno.Me, Inc.'s investors?
- Geno.Me, Inc.'s investors include Excelerate Health Ventures, HealthX Ventures.
- How much funding has Geno.Me, Inc. raised?
- Geno.Me, Inc. has disclosed $2.4M raised across 2 rounds.
- Where is Geno.Me, Inc. headquartered?
- Geno.Me, Inc. is headquartered in Milwaukee, US.
